“…These droplets are subsequently cooled down by falling through a tempered cooling tower and gathered as spheres with narrow size distribution. Main drawback of HME and prilling is the requirement of higher processing temperatures, which are in general not suitable for thermo-labile compounds [Ceowley et al, 2007;Lang et al, 2014;Maniruzzaman et al, 2012;Pivette et al, 2012;Repka et al, 2007;Repka et al, 2012;Sequier et 4 al., 2014;Vervaeck et al, 2013]. Pharmaceutically approved lipids are excipients suitable for production of solid oral dosage forms by melting technologies, due to their biocompatibility, lowtoxicity, compatibility with many active compounds, moderate melting temperatures and low cost.…”